Hormone Testing - Power2Practice...24-Hour Urine Testing Considerations •Expensive...
Transcript of Hormone Testing - Power2Practice...24-Hour Urine Testing Considerations •Expensive...
Hormone TestingJim Paoletti, B.S. Pharmacy, FAARFM
Establish the Need
– Lab tests
– Correlate patient assessment with testing results
– Lab tests alone do not always tell the whole story
– Lab values are guides to which direction therapy should be considered
– Lab values should be used to “confirm the diagnosis”
Testing Considerations
• Limitations– Timing of cycle
– No individual baseline in many cases
– Lack of correlation of symptoms to levels
– No consideration of influences on free hormone levels (such as SHBG)
– Dosage form differences
• Don’t rely on lab tests alone—Treat the patient, not the labs
Testing Considerations
• Are you comparing to the range of a person of the reported life stage or the range of the age you are attempting to replicate?– We don’t want menopausal levels in most cases
Testing Considerations
• When was the test done compared to the timing of the last dose?– Make sure patient is at steady state if possible
• 8 -24 hrs post topical application• 4-8 hrs post oral dosing (SR capsules)
• Be consistent with subsequent testing
• Pay attention to changes in:• Site of application • Base• Volume applied
Body Fluids Commonly Used for Testing Steroid Hormones
• Serum/plasma
• 24-hour urine
• Saliva
• Capillary blood (dried blood spot)
Serum Testing
Advantages
• Wide range of hormones available
• Familiar reference ranges
• Many laboratories to choose from
• Standard automated methods with appropriate proficiency testing
• Insurance coverage
Serum Testing
Considerations
• Established “gold standard” based on evidence for endogenous values, not exogenous administration
• Invasive to the patient - phlebotomist required
• Difficult to measure multiple times during day or month
• Unable to distinguish between bound and unbound hormones
• Progesterone assays do not distinguish between progesterone and its metabolites
• Serum E2 less reflective of loose bound hormone in women
Serum Testing
Considerations• Large normal ranges • Ranges for free and bio-available testosterone
established for men, not sensitive enough for women• Normal testosterone range is often the same for all
adult women, no matter of age Free Androgen Index (Total T ÷ SHBG) often inaccurate
• Hidden costs in patient obtaining sample• Adequate for endogenous hormone measurement• Overestimation for oral supplementation• Underestimation for topical supplementation
Serum Testing
Considerations
• Cortisol in serum– Elevations due to fear of being stuck
– Timing of test vs. normal range timing
– Inconvenient to do multiple tests
– Unrepresentative of normal situation
• Did anyone pay any attention to the time of her cycle?!! – Follicular or Luteal phase
• Current hormone therapy– Not correlated in literature
24-Hour Urine Testing
Advantages
• Non-invasive
• Wide range of hormones available
• Good estimation of total daily production
• Not as subject to the daily ebb and flow of steroid production as serum/saliva
• A good reflection of endogenous steroid production if no supplementation given
24-Hour Urine Testing
Considerations
• Urine Estradiol is not the same as serum estradiol– Serum measures the unconjugated hormone bound
to protein
– Urine measures conjugated estradiol
• Most of conjugates in urine are glucoronides; the kidney excretes estrogen sulphates
24-Hour Urine Testing
Considerations• Expensive• Inconvenient-collection over 24 hrs• Measurement of metabolites
– Assay may not differentiate between a hormone a it’s metabolites
– Measurement of what is being thrown away and not what is bioavailable or being utilized by tissues
– Not getting representation of the active hormone delivered to the tissue with exogenous administration
Urine Testing
• Not Representative of Delivery to Tissue• Progesterone 100mg p.o.
– 90-95% metabolized on first pass effect – 5-10 mg delivered to tissues (bioavailable: 5-10 mg)– Metabolites measured reflect 100mg progesterone
• Progesterone 10 mg topical– ≥90% delivered to tissues– 5-10 mg delivered to tissues (bioavailable: 5-10 mg)– Metabolites measured reflect 10 mg progesterone
Saliva Testing
• First citations in 1960’s
• Commercially available in 1990’s
• Steadily increasing number of citations: – cortisol, estradiol, progesterone, testosterone,
DHEA
Saliva Testing
Considerations• Have to use extracted testing for estradiol
– Direct measurement of E2 is inaccurate and imprecise, and provides no useful clinical results
• Testing procedures must be sensitive enough to differentiate different hormones
• To be clinically useful, need to have established valid reference ranges that consider route, timing of dose, and symptom relieve relative to the level.
Saliva Testing
Considerations• Poor Technique in sample collection or handling
can compromise results– Blood contamination
• Spurious results with periodontal disease (more problem with chewing gum)
– Contamination from supplementation products• Saliva easily contaminated with topical hormones on lips or
hands• Local pooling effect with sublingual administration
– Smaller volumes of saliva will be more variable– Saliva samples should not be pooled for analysis
Saliva Testing
Considerations• Sublingual/Buccal use of hormones leads to
spurious high test results – Direct contamination of the oral mucosa
– Pooling of hormones in oral cavity
– Blood Spot Testing is an excellent alternative for sublingual supplementation
– Makes no sense to stop hormone for a certain period of time and then test (my opinion)
– Makes no sense to give an exaggerated normal range and try to correlate to tissue levels (my opinion)
5 10 25 50 100
TOPICAL DOSE (mg)
0
1000
2000
3000
4000
5000
6000
7000
SA
LIV
AR
Y H
OR
MO
NE
LE
VE
L (
pg
/ml)
Dose-Dependent Increase in Salivary Progesterone and Testosterone
Following Topical Delivery (Mean ± 2 SD)
(4040-6602)(4040-6602)
(n = 238)(n = 238)
(2757-4581)(2757-4581)
(n = 319)(n = 319)
(715-2057)(715-2057)
(n = 31)(n = 31)
(1054-2580)(1054-2580)
(n = 267)(n = 267)
(571-1747)
(n = 39)
(680-2152)(680-2152)
(n = 122)(n = 122)
(1654-2698)(1654-2698)
(n = 90)(n = 90)
(1218-3254)(1218-3254)
(n = 17)(n = 17)
PROGESTERONE
(female)
TESTOSTERONE
(male)
Measurement of Steroid vs. Background
Salivary Estradiol & Hot Flashesin 39,000 women
Salivary Estradiol Concentrationas determined by extracted EIA
Se
lf-R
ep
ort
ed
Ho
t F
lash
Se
ve
rity
ESTROGEN DEFICIENT ESTROGEN EXCESS
Topical Hormone Delivery - The Controversy
• Venipuncture blood (serum or whole blood) suggests poor topical absorption of hormones
• Saliva suggests topical hormones rapidly and efficiently absorbed
• Capillary blood suggests topical hormones rapidly and efficiency absorbed
Saliva Testing and Topical Administration of Hormones
• Demonstrates increase in tissue levels after topical application of hormones
• Linear correlation seen with increasing doses
• Illustrates cumulative effect of topically applied supra-physiological doses
© ZRT Laboratory.LLC 23January 20, 2016
Chang KJ. 1995. Influences of Percutaneous Administration of E2 & Progesterone on Human Breast Epithelial Cell Cycle in vivo.
Application of E2 or Progesterone (20 mg) directly to breasts Intraglandular Steroid Concentration
Placebo Pg
(n=8) (n=7)
Intraglandular Pg (ng/g) 0.6 +/-0.3 66 +/-120
• Progesterone levels increase 100X at the tissue level
2002 04 16 058
Topical Progesterone applied to the breast resulted in significant increase in breast tissue, breast cyst fluid and saliva. Serum and urine levels remained relatively unchanged
600
630
700
730
800
830
900
930
1000
1030
1100
1130
1200
1230
1300
1330
1400
1430
1500
1530
1600
1630
1700
1730
1800
1830
630
0
2
4
6
8
10
12
14
16
18
20-1 0 1 2 3 4 5 6 7 8 9 10 22
SALIVA AND SERUM PROGESTERONE FOLLOWING
PERCUTANEOUS APPLICATION OF 20 MG PROGESTERONEHOURS POST
APPLICATION
TIME OF DAY
PR
OG
ES
TE
RO
NE
(ng
/ml)
SALIVA
SERUM
7:00 8:00 9:00 10:00 11:00 12:00 13:00 14:00 15:00 16:00 17:00 18:00 6:30
WEEK 1
© ZRT Laboratory.LLC 26January 20, 2016
Testosterone Topical Supplementation:Serum Underestimation & Potential Overdosing
0
100
200
300
400
500
600
700
Baseline 6 Hours Post Supplementation
Co
nc
en
tra
tio
n (
ng
/dl)
Testosterone Measurements Post-Supplementation5mg Topical Application
Venous Serum
Venous Blood Spot
Capillary Serum
Capillary Blood Spot
Review of Articles
• Articles examined whether topical progesterone (20-30mg) protected the estrogen-stimulated endometrial lining– All the articles which claimed that topical progesterone failed to
provide protection looked at the serum level and assumed it was too low for the progesterone to provide protection
– The two articles that demonstrated protection biopsied the endometrial tissue and looked at histological changes
Stanczyk, FZ et al. Percutaneous administration of progesterone: blood levels and endometrial protection. Menopause 12(2): 232-237, 2005
Continued
• “Studies investigating the effect of topical cream on the endometrium should not be based on serum progesterone levels but on histologic examination of the endometrium.”
Stanczyk, FZ et al. Percutaneous administration of progesterone: blood levels and endometrial protection. Menopause 12(2): 232-237, 2005
Conclusion
• Conclusion from Stanczyk article: – You cannot use serum value to judge the tissue
effect on the endometrium for topically applied progesterone
• Since topical progesterone concentrates more in the uterus than almost all other tissue, one would have to assume the same conclusion on serum levels would apply to all tissues unless and until proven otherwise
“ Serum progesterone levels may not reflect progesterone levels in a particular tissue..”
“It is now recognized that salivary progesterone levels can increase from baseline levels by at least two orders of magnitude after topical cream application, depending on dose and time of saliva sampling. These findings are consistent with rapid uptake of progesterone by salivary glands. Presumably there is also rapid uptake of progesterone by other tissues, eg, the endometrium..”
Stanczyk, FZ et al. Percutaneous administration of progesterone: blood levels and endometrial protection. Menopause 12(2): 232-237, 2005
Salivary Progesterone with Topical Supplementation (n=1,863)
0
500
1000
1500
2000
2500
3000
0 25 50 75 100
Daily Progesterone Dosage (mg)
Ave
rag
e S
ali
va
ry P
rog
es
tero
ne
(n
g/m
l)
24-Hours Post Supplementation
12-Hours Post Supplementation
Physiological Luteal Levels of Progesterone (75-270)
Conclusions
• When steroid hormones are delivered through the skin, saliva and blood spot hormone levels are more reflective of tissue uptake of steroids than serum hormone levels, but supplementation reference ranges are needed.
RBC
Binding
Protein
Hormone
Epidermis
Dermis
Tissue Cells
Interstitial Fluid
RBC
Binding
Protein
Hormone
Capillary Bed
Tissue Cells
Interstitial Fluid
Blood
SpotSerum
RBC
Binding
Protein
Hormone
HORMONE TESTING IN CAPILLARY BLOOD SPOTS
Dried Blood Spot
• Convenient-Simple at home collection procedure
• Wide range of analytes can be tested-similar to serum/plasma
• More latitude in collection timing• Results equivalent to serum/plasma (except
when supplementing topically)• Dried serum analytes very stable for weeks at
ambient temperature-shipping simplified
Blood Spot Testing: Not a New Concept
Blood Spot Testing: Not a New Concept
Blood Spot
How to?
Advantages (blood spot vs serum)
• No special processing prior to shipment
• Convenient shipment-no biohazard precautions required as per CDC– International Shipments
• Correlates well with serum endogenous levels
Disadvantages
• Vs. serum: limited testing available in blood spot compared to serum/plasma
• Vs. Saliva: not as much data at this point
Why Blood Spot and Not Saliva?
• Allows for testing of larger protein (peptide) molecules– Thyroid, Vitamin D, FSH, LSH, PSA, Cardiometabolic risk
factors
• Reasonable alternative for testing steroid hormones in individuals supplementing as a sublingual or troche
• When steroid hormone test results are combined with hormone binding proteins (eg. SHBG) the ratio provides information on the bioavailable fraction
Hormones Tested By Blood Spot
• Free T3
• Free T4
• TSH
• TPO
• Estradiol
• Progesterone
• Testosterone
• SHBG
• PSA
• Vitamin D
Testosterone Correlation Blood Spot vs. Serum
Estradiol Correlation Blood Spot vs. Serum
Progesterone Correlation - Blood Spot vs. Serum
Blood Spot Progesterone with Topical Supplementation
After 8-12 Hours (n=99)
0
10
20
30
40
50
60
70
80
0 10 20 30 40 50 60 70 80
Daily Progesterone Dosage (mg)
Me
dia
n B
loo
d S
po
t P
rog
es
tero
ne
(n
g/m
l)
Thanks for Listening!Jim Paoletti